C07K 17 - Carrier-bound or immobilised peptides; Preparation thereof

Patents for C07K 17 - Carrier-bound or immobilised peptides; Preparation thereof (10,673)
11/2006
11/16/2006	US20060258849 Nucleic acids and proteins from streptococcus groups A & B
11/16/2006	US20060258848 Human antipneumococcal antibodies from non-human animals
11/16/2006	US20060258847 Exposing a test inhibitor to botulinum toxin light chain;evaluating the biological activity; inhibitors target holotoxin translocation and light chain metalloprotease activity of the botulinum toxin
11/16/2006	US20060258845 Novel purified polypeptides from Staphylococcus aureus
11/16/2006	US20060258843 altered biological persistence; modified botulinum light chain containing a tyrosine phosphorylation site located within the first 10 amino acids of the N-terminal of the modified light chain; for therapy of neuromuscular disorders, autonomic nervous system disorders and pain
11/16/2006	US20060258842 Fully humanized monoclonal antibodies that neutralize Bacillus anthracis lethal toxin; vaccines
11/16/2006	US20060258841 Pancreatic cancer associated antigen, antibody thereto, and diagnostic and treatment methods
11/16/2006	US20060258594 Antibodies to the HIV-1 Tat protein, which bind specifically to a specific epitope found in different HIV-1 strains and subtypes; for use in passive therapy
11/16/2006	US20060257971 Antibodies to pro1561 polypeptide
11/16/2006	US20060257965 Extracellular matrix signalling molecules
11/16/2006	US20060257906 Compositions comprising a library of analytes for detection, quantification and analyses
11/16/2006	US20060257897 Secreted and transmembrane polypeptides and nucleic acids encoding the same
11/15/2006	EP1039921B1 Substantially pure histidine-linked protein polymer conjugates
11/15/2006	CN1864068A Methods for reducing complexity of a sample using small epitope antibodies
11/15/2006	CN1863819A Attachment of cells to surfaces
11/14/2006	US7135177 Immunoliposomes that optimize internalization into target cells
11/09/2006	WO2006119285A1 Combination therapy in the treatment of cancer
11/09/2006	WO2006117227A2 Solid phase bound thymosin alpha-1 and its synthesis
11/09/2006	WO2006116948A1 Interleukin-6 polyethylene glycol conjugate and its preparing method and use
11/09/2006	WO2005056808A3 Immobilization of biocatalysts by template-directed silicate precipitation
11/09/2006	US20060253934 Methods for conditional transgene expression and trait removal in plants
11/09/2006	US20060252691 Topical, oral, intravenous, intraperitoneal, intramuscular, transdermal, nasal, or iontophoretic administration of a RNAIII inhibiting heptapeptide of the sequence Tyr-X2-Pro-X1-Thr-Asn-Phe where X1 is Cys, Trp or Ile, and X2 is Lys or Ser; antibiotic resistance
11/09/2006	US20060252152 Attachment of cells to surfaces
11/09/2006	CA2836827A1 Alpha amino acid ester-drug conjugates hydrolysable by carboxylesterases
11/09/2006	CA2606008A1 Combination therapy in the treatment of cancer
11/09/2006	CA2600303A1 Solid phase bound thymosin alpha-1 and its synthesis
11/08/2006	EP1263800B1 Linker based solid support for peptide and small molecule organic synthesis
11/08/2006	CN1283664C Erythropoietin conjugate
11/07/2006	US7132507 Nucleotide sequences coding polypeptide for use in the treatment of cancer
11/02/2006	WO2006113958A2 Affinity ligands
11/02/2006	WO2006091506A3 Neuropeptide y4 receptor agonists
11/02/2006	US20060247422 Chemically modified G-CSF
11/02/2006	US20060246549 Peptide acceptor ligation methods
11/02/2006	US20060246531 Chemo-enzymatic process for proteome-wide mapping of post-translational modification
11/02/2006	US20060246465 Secreted and transmembrane polypeptides and nucleic acids encoding the same
11/02/2006	US20060246461 Nucleotide sequence coding membrane protein; diagnosis of tumor, cancer
11/02/2006	CA2606222A1 Reagents that bind ccx-ckr2
11/02/2006	CA2606102A1 Modulation of antibody effector function by hinge domain engineering
11/02/2006	CA2605145A1 Affinity ligands
11/01/2006	CN1282658C Novel peptide, novel adsorbent, adsorption unit and adsorption method
10/2006
10/31/2006	US7129213 Tripeptides and tripeptide derivatives for the treatment of neurodegenerative diseases
10/31/2006	US7128911 Virus-like particle, and an antigen or antigenic determinant of a receptor activator factor kappa beta ligand protein, fragment or peptide
10/26/2006	US20060240567 Method of immobilizing a protein to a zeolite
10/26/2006	US20060240036 I-FLICE, a novel inhibitor of tumor necrosis factor receptor-1 and CD-95 induced apoptosis
10/26/2006	DE10003157B4 Verfahren zur Herstellung von funktionalisierten Polyurethanschaumstoffen A method for preparation of functionalized polyurethane foams
10/26/2006	CA2604675A1 Diagnostic and therapeutic potential of immune globulin intravenous (igiv) products
10/25/2006	EP1377275B1 Vaccine for modulating between t1 and t2 immune responses
10/25/2006	CN1850278A Polyethyleneglyol modified recombinant human B lymphocyte stimulating factor and its preparing method
10/25/2006	CN1281626C Method and reagent kit for detecting and measuring 3,4-methylene methedrine (MDMA)
10/25/2006	CN1281611C Mono-methoxy polyethylene glycol derivatives and their preparing process and use
10/24/2006	US7125958 membrane proteins acting as binding ligands to mucopolysaccharide receptors for antigens present on the surfaces of palsmodium infected erythrocytes; drugs; antibodies
10/24/2006	US7125707 Using crystalline cell surface protein for directed monomolecular bonding of molecular layers and/or their attachment to solid support; immobilized cells; micelles
10/24/2006	US7125703 Nucleic acid molecules encoding a transmembrane serine protease 7, the encoded polypeptides and methods based thereon
10/24/2006	US7125669 Solid-phase immobilization of proteins and peptides
10/24/2006	CA2262451C Boronic compound complexing reagents and complexes
10/19/2006	WO2006108594A1 Peptide synthesis of alpha-helixes on peg resin
10/19/2006	US20060234308 Method for determining the substrate specificity of an enzymatic activity and a device therefor
10/19/2006	US20060234255 Novel proteins and nucleic acids encoding same
10/19/2006	US20060233746 N-terminally chemically modified protein compositions and methods
10/19/2006	CA2600291A1 Peptide synthesis of alpha-helixes on peg resin
10/18/2006	EP1712567A1 Protein immobilization method and quantification method
10/18/2006	EP1711196A2 Inhibitors of type 2 vascular endothelial growth factor receptors
10/18/2006	EP1242460B1 Immobilisation of proteins using a polypeptide segment
10/17/2006	US7122629 For forensic analyses, chromosome tissue/cell/organelle-specific markers, production of expression vectors, screening and diagnosis assays
10/17/2006	US7122622 Somatostatin analogue as peptide and chelating group covalently linked to N-terminal free amino group of peptide, wherein analogue carries 1-naphthylalanine or 3-benzothienylalanine residue in 3-position; diagnosis
10/17/2006	US7122524 Stimulating nerve growth, administering glycyl-L-phenylalanyl-L-prolineamide, N,N-diethyl-isoleucyl-phenylalanyl-L-proline ethylamide, N,N-diethyl-isoleucyl-isoleucyl-prolineamide; due to ischemic, traumatic or toxic origin
10/17/2006	US7122382 Synthesizing a protein having a label for detection and another protein having a modification for separation in a single system by the cell-free protein synthesis; separating a pair of proteins formed by the interaction between these proteins
10/17/2006	US7122356 Method for attachment of biomolecules to medical device surfaces
10/17/2006	US7122196 Compounds and methods for diagnosis of tuberculosis
10/12/2006	WO2005117954A3 Compositions and methods for treatment of neovascular diseases
10/12/2006	WO2005012479A3 Antibodies directed to the deletion mutants of epidermal growth factor receptor and uses thereof
10/12/2006	US20060229432 synthetic vaccine; HIV; multi-antigenic construct comprising carbohydrate antigens linked with polypeptides
10/11/2006	EP1709421A1 Methods for diagnosis and pronosis of cancers of epithelial origin
10/11/2006	EP1708750A1 Targeting of erb antigens
10/11/2006	EP1708748A2 Influenza immunogen and vaccine
10/11/2006	EP0896586B1 ErbB3 ANTIBODIES
10/10/2006	US7119181 Nucleic acids and expression vectors; genetic engineering; diagnosis and detection of DNA, RNA or antibodies of the lymphadenopathy retrovirus
10/10/2006	US7119168 Paralytic peptide for use in neuromuscular therapy
10/10/2006	CA2274307C Hypersensitive response induced resistance in plants by seed treatment
10/05/2006	US20060222648 Graft-versus-host disease; inhibit secretion of Interferon-gamma (IFN-?) by lymphocytes or other immune cells in a mammal; inflammatory bowel disease is Crohn's disease, ulcerative colitis, or ileitis; KIM-1 (Kidney Injury Molecule-1)
10/05/2006	US20060222644 Humanized anti-Lymphotoxin beta receptor antibodies
10/05/2006	US20060222565 Method for producing an arrangement comprising a plurality of layers on the base of semiconductor substrate, multi-layer arrangement, and biosensor
10/05/2006	CA2610292A1 Proliferation of muc1 expressing cells
10/04/2006	EP1706420A1 Site-specific coupling of polypeptides
10/04/2006	EP1509336A4 Synthesis of inorganic structures using templation and catalysis by self assembled repeat protein polymers
10/04/2006	EP0964702B1 Polypeptides having a single covalently bound n-terminal water-soluble polymer
10/04/2006	CN1840178A Tumour-specific animal proteins
10/03/2006	US7115798 Methods for regulated expression of triats in plants using multiple site-specific recombination systems
10/03/2006	US7115709 Methods of staining target chromosomal DNA employing high complexity nucleic acid probes
10/03/2006	US7115383 An amphetamine and a methamphetamine group linked by a linking group, a polyamino acid or a nonpolyamino acid label linked to a second linking group which is attached to first linking group at a equidistance from both drugs, and second linking group terminates in a functional group; antiboides; sample
10/03/2006	US7115266 Angiotensin peptide-carrier conjugates and uses thereof
09/2006
09/28/2006	WO2004064608A3 Method for removal of viruses from blood by lectin affinity hemodialysis
09/28/2006	WO2002083872A3 Methods and products of cleaving ssdna using oligonucleotides to form restriction sites
09/28/2006	US20060217304 Long lasting glucagon-like peptide 2 (GLP-2) for the treatment of gastrointestinal diseases and disorders
09/27/2006	EP1705183A1 Binding molecules for human factor VIII and factor VIII-like proteins
09/27/2006	EP1703994A2 Method for coating an object with hydrophobin in the presence of a detergent
09/27/2006	EP1068356B1 Addressable protein arrays
09/27/2006	CN1838967A Stabilized immunogenic HBc chimer particles
09/27/2006	CN1837239A Polypeptide growth factor copolymer and its preparation method and use
09/27/2006	CN1837191A N-acetyl cysteine derivatives and use thereof

1 ... 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 ... 107